928 related articles for article (PubMed ID: 21091654)
1. Principles of early drug discovery.
Hughes JP; Rees S; Kalindjian SB; Philpott KL
Br J Pharmacol; 2011 Mar; 162(6):1239-49. PubMed ID: 21091654
[TBL] [Abstract][Full Text] [Related]
2. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
3. In silico pharmacology for a multidisciplinary drug discovery process.
Ortega SS; Cara LC; Salvador MK
Drug Metabol Drug Interact; 2012; 27(4):199-207. PubMed ID: 23152402
[TBL] [Abstract][Full Text] [Related]
4. Fragment screening to predict druggability (ligandability) and lead discovery success.
Edfeldt FN; Folmer RH; Breeze AL
Drug Discov Today; 2011 Apr; 16(7-8):284-7. PubMed ID: 21315179
[No Abstract] [Full Text] [Related]
5. Integration of small-molecule discovery in academic biomedical research.
Ohlmeyer M; Zhou MM
Mt Sinai J Med; 2010; 77(4):350-7. PubMed ID: 20687180
[TBL] [Abstract][Full Text] [Related]
6. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
7. Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.
Ekert JE; Deakyne J; Pribul-Allen P; Terry R; Schofield C; Jeong CG; Storey J; Mohamet L; Francis J; Naidoo A; Amador A; Klein JL; Rowan W
SLAS Discov; 2020 Dec; 25(10):1174-1190. PubMed ID: 32495689
[TBL] [Abstract][Full Text] [Related]
8. Non-stoichiometric inhibition in integrated lead finding - a literature review.
Klumpp M
Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
[TBL] [Abstract][Full Text] [Related]
9. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel drugs for promising targets.
Martell RE; Brooks DG; Wang Y; Wilcoxen K
Clin Ther; 2013 Sep; 35(9):1271-81. PubMed ID: 24054704
[TBL] [Abstract][Full Text] [Related]
11. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
Campbell JB
IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
[TBL] [Abstract][Full Text] [Related]
12. Biophysics: for HTS hit validation, chemical lead optimization, and beyond.
Genick CC; Wright SK
Expert Opin Drug Discov; 2017 Sep; 12(9):897-907. PubMed ID: 28658992
[TBL] [Abstract][Full Text] [Related]
13. HTS and hit finding in academia--from chemical genomics to drug discovery.
Frearson JA; Collie IT
Drug Discov Today; 2009 Dec; 14(23-24):1150-8. PubMed ID: 19793546
[TBL] [Abstract][Full Text] [Related]
14. The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization.
Bruno A; Costantino G; Sartori L; Radi M
Curr Med Chem; 2019; 26(21):3838-3873. PubMed ID: 29110597
[TBL] [Abstract][Full Text] [Related]
15. [High-throughput Screening Technology for Selective Inhibitors of Transporters and Its Application in Drug Discovery].
Motoyaji T
Yakugaku Zasshi; 2021; 141(4):511-515. PubMed ID: 33790118
[TBL] [Abstract][Full Text] [Related]
16. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
17. [The discovery process in the pharmaceutical industry].
Scatton B
J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic screens as a renewed approach for drug discovery.
Zheng W; Thorne N; McKew JC
Drug Discov Today; 2013 Nov; 18(21-22):1067-73. PubMed ID: 23850704
[TBL] [Abstract][Full Text] [Related]
19. Computer-aided drug discovery research at a global contract research organization.
Kitchen DB
J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
[TBL] [Abstract][Full Text] [Related]
20. The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology.
McDonald PR; Roy A; Chaguturu R
Future Med Chem; 2011 Jul; 3(9):1101-10. PubMed ID: 21806374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
